196 related articles for article (PubMed ID: 19743861)
1. Synthesis and evaluation of lysophosphatidylserine analogues as inducers of mast cell degranulation. Potent activities of lysophosphatidylthreonine and its 2-deoxy derivative.
Iwashita M; Makide K; Nonomura T; Misumi Y; Otani Y; Ishida M; Taguchi R; Tsujimoto M; Aoki J; Arai H; Ohwada T
J Med Chem; 2009 Oct; 52(19):5837-63. PubMed ID: 19743861
[TBL] [Abstract][Full Text] [Related]
2. Identification of lysophosphatidylthreonine with an aromatic fatty acid surrogate as a potent inducer of mast cell degranulation.
Kishi T; Kawana H; Sayama M; Makide K; Inoue A; Otani Y; Ohwada T; Aoki J
Biochem Biophys Rep; 2016 Dec; 8():346-351. PubMed ID: 28955975
[TBL] [Abstract][Full Text] [Related]
3. Ca2+ influx, phosphoinositide hydrolysis, and histamine release induced by lysophosphatidylserine in mast cells.
Lloret S; Moreno JJ
J Cell Physiol; 1995 Oct; 165(1):89-95. PubMed ID: 7559812
[TBL] [Abstract][Full Text] [Related]
4. Identification of a lysophosphatidylserine receptor on mast cells.
Sugo T; Tachimoto H; Chikatsu T; Murakami Y; Kikukawa Y; Sato S; Kikuchi K; Nagi T; Harada M; Ogi K; Ebisawa M; Mori M
Biochem Biophys Res Commun; 2006 Mar; 341(4):1078-87. PubMed ID: 16460680
[TBL] [Abstract][Full Text] [Related]
5. Change in sensitivity to lysophosphatidylserine of mouse bone marrow-derived mast cells during cultivation with fibroblasts.
Murakami M; Umeda M; Kudo I; Inoue K
Int Arch Allergy Appl Immunol; 1991; 96(2):156-60. PubMed ID: 1722781
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylserine-induced activation of mast cells in mice.
Monastra G; Pege G; Zanoni R; Toffano G; Bruni A
J Lipid Mediat; 1991; 3(1):39-50. PubMed ID: 1768839
[TBL] [Abstract][Full Text] [Related]
7. GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position.
Kitamura H; Makide K; Shuto A; Ikubo M; Inoue A; Suzuki K; Sato Y; Nakamura S; Otani Y; Ohwada T; Aoki J
J Biochem; 2012 May; 151(5):511-8. PubMed ID: 22343749
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylserine enhances exogenous type II phospholipase A2-induced activation of rat serosal mast cells.
Hara N; Murakami M; Inoue K; Kudo I
Biol Pharm Bull; 1996 Mar; 19(3):474-6. PubMed ID: 8924921
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylserine analogues differentially activate three LysoPS receptors.
Uwamizu A; Inoue A; Suzuki K; Okudaira M; Shuto A; Shinjo Y; Ishiguro J; Makide K; Ikubo M; Nakamura S; Jung S; Sayama M; Otani Y; Ohwada T; Aoki J
J Biochem; 2015 Mar; 157(3):151-60. PubMed ID: 25320102
[TBL] [Abstract][Full Text] [Related]
10. Carnosine attenuates mast cell degranulation and histamine release induced by oxygen-glucose deprivation.
Shen Y; Zhang S; Fu L; Hu W; Chen Z
Cell Biochem Funct; 2008 Apr; 26(3):334-8. PubMed ID: 18064721
[TBL] [Abstract][Full Text] [Related]
11. Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells.
Magerl M; Lammel V; Siebenhaar F; Zuberbier T; Metz M; Maurer M
Exp Dermatol; 2008 May; 17(5):427-35. PubMed ID: 18331331
[TBL] [Abstract][Full Text] [Related]
12. IL-10 confers protection from mast cell degranulation in a mouse model of allergic conjunctivitis.
Bundoc VG; Keane-Myers A
Exp Eye Res; 2007 Oct; 85(4):575-9. PubMed ID: 17765892
[TBL] [Abstract][Full Text] [Related]
13. Effect of serine phospholipid structure on the enhancement of concanavalin A-induced degranulation in rat mast cells.
Horigome K; Tamori-Natori Y; Inoue K; Nojima S
J Biochem; 1986 Sep; 100(3):571-9. PubMed ID: 2430953
[TBL] [Abstract][Full Text] [Related]
14. Image analysis of mast cell degranulation in a concentration gradient of stimuli formed in the channel between a glass plate and a silicon substrate.
Nitta N; Aoki Y; Isogawa Y; Tsuchiya T; Kanegasaki S
Eur J Cell Biol; 2009 Sep; 88(9):541-9. PubMed ID: 19515452
[TBL] [Abstract][Full Text] [Related]
15. Mast cell degranulation alters lymphatic contractile activity through action of histamine.
Plaku KJ; von der Weid PY
Microcirculation; 2006; 13(3):219-27. PubMed ID: 16627364
[TBL] [Abstract][Full Text] [Related]
16. Group II phospholipase A2 inhibitors suppressed lysophosphatidylserine-dependent degranulation of rat peritoneal mast cells.
Murakami M; Kudo I; Fujimori Y; Suga H; Inoue K
Biochem Biophys Res Commun; 1991 Dec; 181(2):714-21. PubMed ID: 1721808
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of lysophosphatidylserine, a potentiator of histamine release in rat mast cells.
Tamori-Natori Y; Horigome K; Inoue K; Nojima S
J Biochem; 1986 Sep; 100(3):581-90. PubMed ID: 2430954
[TBL] [Abstract][Full Text] [Related]
18. Mast cell activation and degranulation occur early during induction of periosteal bone resorption.
Fouilloux I; Duplan MB; Baroukh B; Cherruau M; Saffar JL; Lesclous P
Bone; 2006 Jan; 38(1):59-66. PubMed ID: 16249129
[TBL] [Abstract][Full Text] [Related]
19. A theoretical model based upon mast cells and histamine to explain the recently proclaimed sensitivity to electric and/or magnetic fields in humans.
Gangi S; Johansson O
Med Hypotheses; 2000 Apr; 54(4):663-71. PubMed ID: 10859662
[TBL] [Abstract][Full Text] [Related]
20. Presence of SNAP-23 and syntaxin 4 in mouse and hamster peritoneal mast cells.
Salinas E; RodrÃguez G; Quintanar JL
Acta Histochem; 2007; 109(6):454-60. PubMed ID: 17485106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
